The anti-inflammatory effects of Hedyotis diffusa Willd on SLE with STAT3 as a key target
- PMID: 35940466
- DOI: 10.1016/j.jep.2022.115597
The anti-inflammatory effects of Hedyotis diffusa Willd on SLE with STAT3 as a key target
Abstract
Ethnopharmacological relevance: Hedyotis diffusa Willd, also named Scleromitrion diffusum (Willd.) R.J. Wang, is one medical herb, which has been traditionally used by the She nationality in China. And H. diffusa represents a beneficial effect on Systemic lupus erythematosus (SLE) treatment in clinic.
Aim of the study: The underlying mechanisms of the protective effects of H. diffusa on SLE remain unclear. In this study, we treated MRL/lpr mice with H. diffusa water extract (HDW) to assess its therapeutic effects and verified its regulating signalling pathway through cytological experiments.
Materials and methods: In the present study, the constituents of HDW were analysed through ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) and SCIEX OS software. The protective activity and underlying mechanisms were studied in a MRL/lpr lupus mouse model. The blood cells, autoantibodies, metabolites and the cytokines in serum were identified with a hematology analyzer, specific ELISA kit, GC/MS system and cytometric assays. The histological and immunohistochemical analysis were engaged in the morphologic, and the expression and translocation of the crucial protein observation. The dual luciferase reporter assay was applied to identifying the regulative activity of HDW. The transcription and translation expression of the protein was studied by real-time PCR and Western blot assays. The network pharmacology analysis was employed to predict the IL-6/STAT3 pathway regulators and the screen the STAT3 inhibitors in HDW.
Results: The results revealed the capability of HDW to attenuate the production of autoantibodies, secretion of inflammatory cytokines (IL-6 and IFN-γ), and suppressed the IgG and C3 deposition, the development of glomerular lesions in MRL/lpr mice. Serum metabolomics study showed the improvement in serum metabolites, especially aminoacyl-tRNA biosynthesis, by HDW. IL-6 was clarified to be highly associated with the significantly changed metabolites in network analysis. We further demonstrated the effects of HDW on the IL-6/STAT3 pathway in vivo and in vitro.
Conclusions: This study suggested that HDW exerts a therapeutic effect in SLE model mice by suppressing the IL-6/STAT3 pathway.
Keywords: Autoantibodies; Hedyotis diffusa Willd; IL-6/STAT3 signalling pathway; MRL/lpr mice; SLE.
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
The protective capability of Hedyotis diffusa Willd on lupus nephritis by attenuating the IL-17 expression in MRL/lpr mice.Front Immunol. 2022 Jul 25;13:943827. doi: 10.3389/fimmu.2022.943827. eCollection 2022. Front Immunol. 2022. PMID: 35958622 Free PMC article.
-
The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.J Ethnopharmacol. 2016 Nov 4;192:132-139. doi: 10.1016/j.jep.2016.07.027. Epub 2016 Jul 15. J Ethnopharmacol. 2016. PMID: 27426510
-
Chemical Profiles and Protective Effect of Hedyotis diffusa Willd in Lipopolysaccharide-Induced Renal Inflammation Mice.Int J Mol Sci. 2015 Nov 13;16(11):27252-69. doi: 10.3390/ijms161126021. Int J Mol Sci. 2015. PMID: 26580602 Free PMC article.
-
Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanisms.Biomed Pharmacother. 2020 Oct;130:110735. doi: 10.1016/j.biopha.2020.110735. Epub 2020 Sep 12. Biomed Pharmacother. 2020. PMID: 34321173
-
Isolation, purification, structural characteristics, pharmacological activities, and combined action of Hedyotis diffusa polysaccharides: A review.Int J Biol Macromol. 2021 Jul 31;183:119-131. doi: 10.1016/j.ijbiomac.2021.04.139. Epub 2021 Apr 24. Int J Biol Macromol. 2021. PMID: 33905802 Review.
Cited by
-
Unveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking study.Discov Oncol. 2025 Jun 6;16(1):1016. doi: 10.1007/s12672-025-02633-w. Discov Oncol. 2025. PMID: 40478357 Free PMC article.
-
Scleromitrion diffusum (Willd.) R. J. Wang Inhibits Gastric Cancer via ERBB2/ERBB3/PI3K/AKT Pathway.Turk J Gastroenterol. 2024 Nov 1;35(11):831-838. doi: 10.5152/tjg.2024.24152. Turk J Gastroenterol. 2024. PMID: 39549017 Free PMC article.
-
Phytochemistry, pharmacology, and medical uses of Oldenlandia (family Rubaceae): a review.Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2021-2053. doi: 10.1007/s00210-023-02756-3. Epub 2023 Oct 14. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37837473 Review.
-
Identification of Hedyotis diffusa Willd-specific mRNA-miRNA-lncRNA network in rheumatoid arthritis based on network pharmacology, bioinformatics analysis, and experimental verification.Sci Rep. 2024 Mar 15;14(1):6291. doi: 10.1038/s41598-024-56880-y. Sci Rep. 2024. PMID: 38491124 Free PMC article.
-
Network pharmacology, bioinformatics, and experimental validation to identify the role of Hedyotis diffusa willd against gastric cancer through the activation of the endoplasmic reticulum stress.Heliyon. 2024 Mar 30;10(7):e28833. doi: 10.1016/j.heliyon.2024.e28833. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38576568 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous